Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-28

Clinical Trial Update: Ketamine Infusion vs Dexmedetomidine Infusion in Obese Patients Undergoing Bariatric Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing ketamine infusion to dexmedetomidine infusion in obese patients undergoing bariatric surgery; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)
  • Ketamine (ketamine)

Snippet

Sponsor: Ain Shams University | Conditions: Morbid Obesity, Surgery | Phase 3 | Status: UNKNOWN